Practice-changing data in lung cancer, prostate cancer and more were on display over the weekend at the American Society of Clinical Oncology annual meeting in Chicago. Plus, early readouts on assets that could reshape the cancer landscape.
ASCO: A battle of bispecifics, Eli Lilly’s big win and more Read More »
Un nuevo estudio ha permitido describir el mecanismo mecano-químico por el cual la acidez del entorno celular desestabiliza los microtúbulos, las “avenidas” que organizan el tráfico interno de las células. Este hallazgo resulta vital para conocer a fondo patolog …
El impacto de la inteligencia artificial generativa en la educación superior es objeto de un intenso debate. En muchos sentidos, la tecnología está haciendo que las formas habituales de evaluación, como los exámenes, los proyectos o los trabajos de fin de curso, se …
Uso indebido de inteligencia artificial por el alumnado en la educación superior Read More »
Swiss service provider CordenPharma is acquiring AmbioPharm, gaining facilities such as a plant in South Carolina to provide a fully U.S.-based supply.
CordenPharma inks AmbioPharm buyout to continue peptide production expansion Read More »
Edgewise Therapeutics will now focus on a handful of cardiovascular programs including EDG-7500 for hypertrophic cardiomyopathy thanks to the non-dilutive capital from France’s Servier.
Servier frees Edgewise for cardio mission with $2.65B muscular dystrophy deal Read More »
Seventeen life sciences businesses awarded Massachusetts tax incentives to add and retain 426 combined jobs hit 10% of that target as of Dec. 31. Three companies, including Novartis, had reported layoffs either last year or this year.
17 companies expected to create 400+ Massachusetts jobs add under 50 Read More »
Riding a newfound surge of interest on infectious disease concerns, Moderna is linking up with a global vaccine foundation in hopes of developing a vaccine to slow the new surge in Ebola underway in the Congo and Uganda.
Moderna partners with CEPI on Ebola vaccine efforts amid outbreak in Africa Read More »
“King Keytruda’s reign continues,” analysts at BMO Capital Markets declared after Chinese data for Summit Therapeutics’ ivonescimab were revealed at the American Society for Clinical Oncology in Chicago.
ASCO: Summit reached with China lung data but new climb begins to prove global benefit Read More »
El ritmo del día a día, las comidas rápidas y el estrés acumulado suelen pasarle una factura muy cara a tu microbiota. Tu intestino está librando una batalla diaria y, a veces, necesita un poco de ayuda extra para no colapsar. Aquí es donde entran …
Revolución intestinal: ¿Cómo recuperar la ligereza y el bienestar que tu cuerpo te pide? Read More »
Revolution Medicines and its RAS inhibitor daraxonrasib stole the show at the American Society of Clinical Oncology’s annual meeting this weekend, as Truist Securities predicts a possible third quarter launch for the pancreatic cancer drug.
